208 related articles for article (PubMed ID: 23241371)
21. The New Aptima HCV Quant Dx Real-time TMA Assay Accurately Quantifies Hepatitis C Virus Genotype 1-6 RNA.
Chevaliez S; Dubernet F; Dauvillier C; Hézode C; Pawlotsky JM
J Clin Virol; 2017 Jun; 91():5-11. PubMed ID: 28380393
[TBL] [Abstract][Full Text] [Related]
22. Analytical performance of the VERIS MDx system HCV assay for detecting and quantifying HCV RNA.
Sauné K; Abravanel F; Haslé C; Boineau J; Mengelle C; Izopet J
J Clin Virol; 2016 Nov; 84():7-11. PubMed ID: 27636506
[TBL] [Abstract][Full Text] [Related]
23. Performance characteristics of a quantitative hepatitis C virus RNA assay using COBAS AmpliPrep total nucleic acid isolation and COBAS taqman hepatitis C virus analyte-specific reagent.
Forman MS; Valsamakis A
J Mol Diagn; 2008 Mar; 10(2):147-53. PubMed ID: 18276771
[TBL] [Abstract][Full Text] [Related]
24. Comparative performance of two commercial sample-to-result systems for hepatitis C virus quantitation and genotyping.
Yip CCY; Sridhar S; Lau JHN; Cheng AKW; Leung KH; Chen JHK; Chan KH; Cheng VCC; Yuen KY
Expert Rev Mol Diagn; 2020 Dec; 20(12):1253-1258. PubMed ID: 32893699
[TBL] [Abstract][Full Text] [Related]
25. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5.
Sarrazin C; Gärtner BC; Sizmann D; Babiel R; Mihm U; Hofmann WP; von Wagner M; Zeuzem S
J Clin Microbiol; 2006 Mar; 44(3):729-37. PubMed ID: 16517847
[TBL] [Abstract][Full Text] [Related]
26. Verification of the Roche cobas
Tan NK; Carrington D; Pope CF
J Med Microbiol; 2018 Dec; 67(12):1711-1717. PubMed ID: 30325300
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
[TBL] [Abstract][Full Text] [Related]
28. Improved COBAS TaqMan hepatitis C virus test (Version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite study.
Colucci G; Ferguson J; Harkleroad C; Lee S; Romo D; Soviero S; Thompson J; Velez M; Wang A; Miyahara Y; Young S; Sarrazin C
J Clin Microbiol; 2007 Nov; 45(11):3595-600. PubMed ID: 17898157
[TBL] [Abstract][Full Text] [Related]
29. Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV realtime assay [corrected] and VERSANT HCV RNA assay.
Tuaillon E; Mondain AM; Ottomani L; Roudière L; Perney P; Picot MC; Séguret F; Blanc F; Larrey D; Van de Perre P; Ducos J
J Clin Microbiol; 2007 Sep; 45(9):3077-81. PubMed ID: 17581929
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the QIAGEN artus HCV QS-RGQ test with the Roche COBAS Ampliprep/COBAS TaqMan HCV test v2.0 for the quantification of HCV-RNA in plasma samples.
Schønning K
J Clin Virol; 2014 Aug; 60(4):323-7. PubMed ID: 24894603
[TBL] [Abstract][Full Text] [Related]
31. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
Gelderblom HC; Menting S; Beld MG
Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test.
Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
J Clin Microbiol; 2000 Aug; 38(8):2933-9. PubMed ID: 10921954
[TBL] [Abstract][Full Text] [Related]
33. Rapid point-of-care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection.
Bregenzer A; Warmann N; Ottiger C; Fux CA
Swiss Med Wkly; 2019 Oct; 149():w20137. PubMed ID: 31656039
[TBL] [Abstract][Full Text] [Related]
34. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China.
Xu S; Song A; Nie J; Li X; Meng S; Zhang C; Wang Y
J Clin Virol; 2012 Jan; 53(1):33-7. PubMed ID: 22051503
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.
Ronsin C; Pillet A; Bali C; Denoyel GA
J Clin Microbiol; 2006 Apr; 44(4):1390-9. PubMed ID: 16597867
[TBL] [Abstract][Full Text] [Related]
36. Performance of the New Aptima HCV Quant Dx Assay in Comparison to the Cobas TaqMan HCV2 Test for Use with the High Pure System in Detection and Quantification of Hepatitis C Virus RNA in Plasma or Serum.
Schalasta G; Speicher A; Börner A; Enders M
J Clin Microbiol; 2016 Apr; 54(4):1101-7. PubMed ID: 26865682
[TBL] [Abstract][Full Text] [Related]
37. Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy.
Mücke MM; Maasoumy B; Dietz J; Mücke VT; Simon CO; Canchola JA; Cornberg M; Marins EG; Manns MP; Zeuzem S; Wedemeyer H; Sarrazin C; Vermehren J
PLoS One; 2019; 14(11):e0224751. PubMed ID: 31738773
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C Virus RNA Real-Time Quantitative RT-PCR Method Based on a New Primer Design Strategy.
Chen L; Li W; Zhang K; Zhang R; Lu T; Hao M; Jia T; Sun Y; Lin G; Wang L; Li J
J Mol Diagn; 2016 Jan; 18(1):84-91. PubMed ID: 26612712
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?
Trimoulet P; Merchadou L; Winnock M; Loko MA; Fleury H; Salmon D; Dabis F; Neau D;
J Virol Methods; 2012 Apr; 181(1):131-3. PubMed ID: 22285372
[TBL] [Abstract][Full Text] [Related]
40. Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment.
Wiesmann F; Naeth G; Berger A; Hirsch HH; Regenass S; Ross RS; Sarrazin C; Wedemeyer H; Knechten H; Braun P
Med Microbiol Immunol; 2016 Jun; 205(3):263-8. PubMed ID: 26666643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
